Viewing Study NCT07391566


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-26 @ 3:15 PM
Study NCT ID: NCT07391566
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-06
First Post: 2025-12-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
Sponsor: Luye Pharma Group Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module